Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA, et al. Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; Results of a first-in-human Phase I trial. Clin Cancer Res 2021 Jun 2. pii: 1078-0432.CCR-21-0611.
PMID: 34078652